C5ORF44 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.44089209850063E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.2797319587653E-12 |
Normal-vs-Stage2 |
6.795700E-04 |
Normal-vs-Stage3 |
8.88178419700125E-16 |
Normal-vs-Stage4 |
1.62458935193399E-12 |
Stage1-vs-Stage2 |
2.939400E-01 |
Stage1-vs-Stage3 |
1.179970E-02 |
Stage1-vs-Stage4 |
4.360600E-03 |
Stage2-vs-Stage3 |
9.178900E-03 |
Stage2-vs-Stage4 |
9.003300E-03 |
Stage3-vs-Stage4 |
8.106800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62503344114384E-12 |
Normal-vs-AfricanAmerican |
1.04729999994557E-06 |
Normal-vs-Asian |
5.439300E-03 |
Caucasian-vs-AfricanAmerican |
8.920400E-01 |
Caucasian-vs-Asian |
7.576400E-01 |
AfricanAmerican-vs-Asian |
8.370800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
6.98210378402564E-11 |
Male-vs-Female |
3.432100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.67654778948645E-12 |
Normal-vs-Age(41-60Yrs) |
6.21724893790088E-15 |
Normal-vs-Age(61-80Yrs) |
1.74815717457477E-12 |
Normal-vs-Age(81-100Yrs) |
6.33129999999538E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.020710E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.020000E-04 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.758300E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.011200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.825000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.689800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.197580E-01 |
Normal-vs-Grade 2 |
2.23540075339201E-11 |
Normal-vs-Grade 3 |
1.62769797640294E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
6.387400E-01 |
Grade 1-vs-Grade 3 |
4.505800E-01 |
Grade 1-vs-Grade 4 |
7.822200E-02 |
Grade 2-vs-Grade 3 |
9.544100E-02 |
Grade 2-vs-Grade 4 |
1.40720000096906E-08 |
Grade 3-vs-Grade 4 |
2.38779999999217E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.16889999796288E-08 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
3.98630000000288E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.55346912689947E-13 |
Normal-vs-N1 |
8.81669959262865E-10 |
N0-vs-N1 |
4.655600E-02 |
|
|